No products from this compounder that are marked as sterile should be administered to patients, as microbial contamination can put patients at risk for severe infections.
Hospitals and healthcare providers should quarantine any such products and await further instructions, according to the release.
More Articles on Anesthesia:
Maquet’s SERVO-i Ventilator Battery Module Given Class 1 Recall
FDA: Pregnant Women Should Avoid Valproate Drug for Migraine Prevention
Masimo Rainbow Respiratory Monitor Cleared by FDA for Pediatric Use
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
